This study is looking at whether POWER-MS can help people with Multiple Sclerosis or depression. Participants take part in POWER-MS and complete follow-up assessments.
This study is testing a medication approach for people with depression or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with depression, Mental Imagery, or Cognitive Behavioral Therapy. Participants take part in the program and complete follow-up questionnaires or assessments.
In Amsterdam
Why is this study shown?
This study is directly about Depression.
DepressionBehavioralOver 18 Years
Countries
Netherlands
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
This observational study is following people with depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing Celecoxib with placebo for people with depression or Inflammation. Participants receive Celecoxib or placebo and complete study visits and assessments.
Multiple locations, including Duffel
Why is this study shown?
This study is directly about Depression.
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
This study is looking at whether a digital support tool can help people with Schizophrenia and Related Disorders, depression, or Depression in bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.
In Ramat Gan
Why is this study shown?
This study is directly about Depression.
Depression, Bipolarity, ...DrugFrom 18 Years to 70 Years
This study is looking at whether Soybean oil (Standard treatment) can help people with depression. Participants take part in Soybean oil (Standard treatment) and complete follow-up assessments.
This study is looking at whether Neurobehavioral therapy can help people with depression or Epilepsy. Participants take part in Neurobehavioral therapy and complete follow-up assessments.
In Houston
Why is this study shown?
This study is directly about Depression.
DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
This study is comparing Ketamine with placebo for people with depression. Participants receive Ketamine or placebo and complete study visits and assessments.
This study is looking at examine the efficacy and safety of an NMDA enhancer (NMDAE) in the treatment of antidepressant nonresponders with depression for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing NMDAE with placebo for people with depression. Participants receive NMDAE or placebo and complete study visits and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.